NDC 51672-4044-01 - Clorazepate Dipotassium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-4044
- Requested NDC
- 51672-4044-01
- Package NDCs from labels
- 51672-4044-1, 51672-4044-2, 51672-4044-3, 51672-4044-01
- Manufacturer
- PD-Rx Pharmaceuticals, Inc.
- Effective date
- 2026-09-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Clorazepate Dipotassium Tablets USP 15 mg | PD-Rx Pharmaceuticals, Inc. | 2026-09-14 | HUMAN PRESCRIPTION DRUG LABEL |
| Clorazepate Dipotassium - Clinical Solutions Wholesale, LLC | Clinical Solutions Wholesale, LLC | 2026-07-24 | HUMAN PRESCRIPTION DRUG LABEL |
| Clorazepate Dipotassium Tablets USP, 3.75 mg, 7.5 mg, & 15 mg | Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries, Ltd. | 2026-07-14 | HUMAN PRESCRIPTION DRUG LABEL |
| Clorazepate Dipotassium - Coupler LLC | Coupler LLC | 2025-01-28 | HUMAN PRESCRIPTION DRUG LABEL |
| Clorazepate Dipotassium Tablets USP, 15 mg | PD-Rx Pharmaceuticals, Inc. | 2025-01-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-4044-1 | Clorazepate Dipotassium | 100 in 1 BOTTLE | TABLET | 100 | 7 | |
| 51672-4044-2 | Clorazepate Dipotassium | 500 in 1 BOTTLE | TABLET | 500 | 7 | |
| 51672-4044-3 | Clorazepate Dipotassium | 1000 in 1 BOTTLE | TABLET | 1000 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-4044 | CLORAZEPATE DIPOTASSIUM TABLET [TARO PHARMACEUTICALS U.S.A., INC.] | 7 | Current NDC, Legacy NDC, 3 package rows | 20240926_499a6989-8912-44b7-b1eb-ee8f85ae378f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-4044-1 | EA - Each | 51672-4044 | 2dca8912-9c73-4790-a352-6b367bfb3b20 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Silica marina | SILICON DIOXIDE | Boiron | 81442e86-bef4-4992-e053-2a91aa0a2453 | 2023-11-15 | ETJ7Z6XBU4 | |
| Silicea | SILICON DIOXIDE | Boiron | 86d2b8f2-dce0-c136-e053-2991aa0a0fdb | 2023-11-15 | ETJ7Z6XBU4 | |
| Silicea | SILICON DIOXIDE | Boiron | 86d31d98-dd71-870e-e053-2991aa0a0ce7 | 2023-11-15 | ETJ7Z6XBU4 | |
| Silicea | SILICON DIOXIDE | Boiron | 86d3ffad-5be4-700a-e053-2991aa0a1cc9 | 2023-11-15 | ETJ7Z6XBU4 | |
| Silicea | SILICON DIOXIDE | Boiron | 86d3206e-a893-3f0c-e053-2991aa0a149f | 2023-11-15 | ETJ7Z6XBU4 | |
| Silicea | SILICON DIOXIDE | Boiron | 86d3d6ca-8b63-2e63-e053-2991aa0a0e05 | 2023-11-15 | ETJ7Z6XBU4 | |
| Potassium Chloride | POTASSIUM CHLORIDE | Sun Pharmaceutical Industries, Inc. | 0a1f2f64-3b0b-5e5c-e063-6294a90a7185 | 2023-11-14 | Warnings, Adverse reactions | 660YQ98I10 |
| Kali carbonicum | POTASSIUM CARBONATE | Boiron | 860662e1-3f4c-846b-e053-2a91aa0ab2d5 | 2023-11-13 | BQN1B9B9HA | |
| Kali carbonicum | POTASSIUM CARBONATE | Boiron | a78ba660-7bd0-11e6-bfe9-424c58303031 | 2023-11-13 | BQN1B9B9HA | |
| Kali muriaticum | POTASSIUM CHLORIDE | Boiron | 86093c75-6de0-bb16-e053-2991aa0ab6ef | 2023-11-13 | 660YQ98I10 | |
| Kali muriaticum | POTASSIUM CHLORIDE | Boiron | 86090ebb-0fb2-2c9c-e053-2a91aa0a0561 | 2023-11-13 | 660YQ98I10 | |
| Kali carbonicum | POTASSIUM CARBONATE | Boiron | 86075ee7-1edd-9265-e053-2a91aa0a5cc2 | 2023-11-13 | BQN1B9B9HA | |
| Kali muriaticum | POTASSIUM CHLORIDE | Boiron | 8608a8de-8133-1d4b-e053-2991aa0a907a | 2023-11-13 | 660YQ98I10 | |
| Kali carbonicum | POTASSIUM CARBONATE | Boiron | 860688c2-1da4-4f79-e053-2991aa0a8c68 | 2023-11-13 | BQN1B9B9HA | |
| Kali muriaticum | POTASSIUM CHLORIDE | Boiron | 860887e7-7eaf-78c2-e053-2991aa0a9a75 | 2023-11-13 | 660YQ98I10 | |
| Kali muriaticum | POTASSIUM CHLORIDE | Boiron | 86086aab-c411-7cf2-e053-2991aa0a81bd | 2023-11-13 | 660YQ98I10 | |
| Kali muriaticum | POTASSIUM CHLORIDE | Boiron | 8608a379-c3b7-3053-e053-2a91aa0a2e65 | 2023-11-13 | 660YQ98I10 | |
| Kali muriaticum | POTASSIUM CHLORIDE | Boiron | 8608f3dd-31bf-0182-e053-2991aa0a1030 | 2023-11-13 | 660YQ98I10 | |
| Potassium Chloride | POTASSIUM CHLORIDE | Lupin Pharmaceuticals, Inc. | 1f33bcfe-c28a-4800-9241-685d974a5d91 | 2023-11-08 | Warnings, Adverse reactions | 660YQ98I10 |
| CV TOX | COCHLEARIA ARMORACIA, ECHINACEA (ANGUSTIFOLIA), LOMATIUM DISSECTUM, TABEBUIA IMPETIGINOSA, HYDRASTIS CANADENSIS, PROPOLIS, GLANDULA SUPRARENALIS BOVINE, THYMUS (SUIS), ARANEA DIADEMA, IPECACUANHA, LYCOPODIUM CLAVATUM, MURIATICUM ACIDUM, NITRICUM ACIDUM, PHOSPHORICUM ACIDUM, RHUS TOX, SILICEA, EPSTEIN-BARR VIRUS NOSODE, HERPES ZOSTER NOSODE, MORBILLINUM, POLIOMYELITIS NOSODE, HEPATITIS B NOSODE, COXSACKIE B1 NOSODE, CYTOMEGALOVIRUS NOSODE, COXSACKIE B4 NOSODE, EPSTEIN BARR VIRUS NOSODE | BioActive Nutritional, Inc. | 8ef2fb5c-1b24-46a1-8d21-a78ce0a34a87 | 2023-11-07 | Warnings | ETJ7Z6XBU4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.